Biomed Private

Bio-Med Private Limited is an established Indian biopharmaceutical company specializing in the development, manufacture, and marketing of human and veterinary vaccines. Founded in 1972 and headquartered in Ghaziabad, Uttar Pradesh, the company has pioneered several indigenous vaccine technologies in India, including the country's first indigenously manufactured Vi antigen typhoid vaccine (Bio Typh) and the world's first Typhoid Vi Conjugate Vaccine (Peda Typh). Bio-Med's human product portfolio also includes vaccines for meningococcal meningitis, Haemophilus influenzae type b (Hib), poliomyelitis, varicella, and rabies, alongside Boto Genie, India's first indigenously manufactured Botulinum Toxin Type A. Additionally, the company manufactures a wide range of veterinary vaccines for poultry, cattle, and sheep, contributing significantly to livestock health across the Indian subcontinent.